Is Biopharma Ready for AI? Exploring Tech Strategies Across Large and Small Biopharma

Biopharma companies face unique challenges in scaling AI-and those challenges vary greatly depending on whether you’re at a small or large biopharma. While large biopharma is pushing ahead with nearly 3x the rate of AI adoption of smaller companies (73% vs. 26%), gaps in AI readiness are evident across both segments, according to the upcoming State of Tech in Biopharma report.

Just 14% of large biopharma and 3% of small biopharma report being fully prepared for AI across the critical dimensions of talent, data, high-throughput automation, and compute. Small companies face structural barriers with access to high-quality, well-structured data and metadata, while large companies’ biggest gap is in a connected wet and dry lab. In this webinar, experts from AbbVie and Benchling will share insights into the current tech landscape, AI readiness, and the strategies for digital transformation shaping large and small biopharma.



The webinar will discuss how both groups are adapting their tech strategy with a focus on the R&D data platforms, robotics, SaaS, and connected instruments used to streamline workflows, create FAIR data (findable, accessible, interoperable, reproducible), and power AI/ML..